GLP Watchdog

Brello Health vs SkinnyRx

SkinnyRx has an open FDA warning letter dated February 20, 2026. Brello Health has none. No price lines up like for like. They share compounded semaglutide injection, but Brello Health's $157.72 is a 3-month prepaid rate, while SkinnyRx's $99 is a first-month price.

To see where both sit among the other sellers, read our best weight-loss injection providers board.

By Ruth Calder · Enforcement Editor
Editorially reviewed. Not medical advice · How we verify contentLast reviewed

The record

Brello Health / SkinnyRx

Brello Health logo

Brello Health

8.1/10

Featured pick (affiliate partner)

SkinnyRx logo

SkinnyRx

6.3/10

FDA warning letters
None on record
Pharmacy
None named in our record
Lowest standing price
$157.72/moCompounded semaglutide injection, 3-month prepaid plan
$248/moBrand-name semaglutide pill
States
40 states and DC
47 states
Checked
Prices captured Record checked October 2026
Prices captured Record checked October 2026
Visit Brello Health
Visit SkinnyRx

SkinnyRx is our featured pick on this page because it is an affiliate partner: we are paid if you sign up through our link. Brello Health pays us nothing. The scores are computed the same way for both and are shown as computed (Brello Health 8.1, SkinnyRx 6.3). How we are paid

What the record shows

  1. 01

    SkinnyRx has an open FDA warning letter dated February 20, 2026. Brello Health has none.

  2. 02

    Brello Health names SouthEnd Pharmacy, a 503A pharmacy. SkinnyRx names no compounding pharmacy in our record.

  3. 03

    No price lines up like for like. They share compounded semaglutide injection, but Brello Health's $157.72 is a 3-month prepaid rate, while SkinnyRx's $99 is a first-month price.

  4. 04

    Only SkinnyRx lists a price for brand-name semaglutide pen, brand-name tirzepatide pen and compounded oral semaglutide.

  5. 05

    Brello Health covers two states SkinnyRx does not and SkinnyRx covers nine states Brello Health does not.

  6. 06

    Brello Health holds you to a 3-month prepay (6-month plan optional); SkinnyRx states you can cancel at any time.

Prices and terms, product by product

A price is set against the other side only for the same product, and only when both are standing monthly or 4-week rates. Those pairs are compared by yearly cost.

Brello Health

SkinnyRx

Compounded semaglutide injection

$157.72/mo

3-month prepaid plan; not compared

$99/mo

first month only; not compared

Compounded tirzepatide injection

$176.69/mo

6-month prepaid plan; not compared

$99/mo

first month only; not compared

Brand-name semaglutide pen
Not sold or not priced

$1,400/mo

$16,800 a year

Brand-name tirzepatide pen
Not sold or not priced

$1,400/mo

$16,800 a year

Compounded oral semaglutide
Not sold or not priced

$149/mo

first month only; not compared

Compounded oral tirzepatide
Not sold or not priced

$199/mo

first month only; not compared

Brand-name semaglutide pill
Not sold or not priced

$248/mo

$2,976 a year

Foundayo (orforglipron) pill
Not sold or not priced

$248/mo

$2,976 a year

Price includes
Medication, clinician visits
Medication, clinician visits, shipping
Cancel any time
No
Yes, stated
Minimum term
3-month prepay (6-month plan optional)
None stated; subscriptions auto-renew until canceled at least 5 days before the renewal date
Refunds
Full refund before a prescription; $50 fee within 24 hours after; none once dispensed
Full refund before a provider completes the prescription review; no refunds for partially used subscription periods

Read off each seller’s own pages. Brello Health: October 25, 2026. SkinnyRx: October 30, 2026. Every plan and dose we hold is on the full review.

The case for each

The case for Brello Health

8.1/10
  • No FDA warning letter on record
  • Names its compounding pharmacy
  • Minimum commitment before you can cancel
  • Lowest price is a 3-month prepaid rate
Visit Brello Health

The case for SkinnyRx

6.3/10
Featured pick (affiliate partner)
  • Sells brand-name semaglutide pen and brand-name tirzepatide pen, which Brello Health does not price
  • Lists 47 states against 40
  • States you can cancel at any time
  • Open FDA warning letter, February 20, 2026
  • Names no compounding pharmacy
Visit SkinnyRx

Scores

Brello Health 8.1 · SkinnyRx 6.3 out of 10. Six weighted parts.

Value25%

6.0A
vs
B
5.6

Effectiveness25%

10.0A
vs
B
10.0

User Experience15%

8.0A
vs
B
3.0

Trust & Safety15%

10.0A
vs
B
2.0

Accessibility10%

8.4A
vs
B
9.5

Support10%

5.5A
vs
B
7.0

The score is the same formula for every seller. Payment does not enter it. Method

Brello Health vs SkinnyRx: questions

SkinnyRx has an open FDA warning letter dated February 20, 2026. Brello Health has none. Letters are matched to a seller by company, domain and address, never by a similar name.
Brello Health names SouthEnd Pharmacy, a 503A pharmacy. SkinnyRx names no compounding pharmacy in our record. A 503A pharmacy compounds for named patients on a prescription; a 503B outsourcing facility is registered with FDA and inspected under federal manufacturing rules.
No price lines up like for like. They share compounded semaglutide injection, but Brello Health's $157.72 is a 3-month prepaid rate, while SkinnyRx's $99 is a first-month price. We only set two prices against each other when they are for the same product and both are standing month-to-month or 4-week rates.
Brello Health has a minimum term (3-month prepay (6-month plan optional)). SkinnyRx states you can cancel at any time; refunds: full refund before a provider completes the prescription review; no refunds for partially used subscription periods.
SkinnyRx is our featured pick on this page because it is an affiliate partner: we are paid if you sign up through our link. Brello Health pays us nothing. The scores are computed the same way for both and are shown as computed (Brello Health 8.1, SkinnyRx 6.3).

Other sellers we are paid by

Affiliate partners outside this pair. Each has its own record and review, scored the same way.

Sellers closest to these two

Matched on molecule, form and price. Every pair we list · The register

Brand names on this page are registered marks. Novo Nordisk holds Wegovy®, Ozempic® and Rybelsus®; Eli Lilly holds Zepbound®, Mounjaro® and Foundayo®. Neither company has any tie to GLP Watchdog. Trademarks